Searched over 200M research papers
10 papers analyzed
These studies suggest hypertensive disorders, including those in pregnancy, are prevalent and complex, with significant implications for maternal and offspring health, and potential management strategies include immunomodulation, omic methods, and early screening.
20 papers analyzed
Hypertension, commonly known as high blood pressure, is a multifactorial disorder with serious health implications. It affects over a billion adults globally and is a leading cause of cardiovascular diseases, including stroke and myocardial infarction. Hypertensive disorders of pregnancy (HDP), which include chronic hypertension, gestational hypertension, and pre-eclampsia, are significant contributors to maternal and fetal morbidity and mortality .
Hypertension is characterized by elevated blood pressure and is influenced by genetic, environmental, and immunological factors. Recent studies suggest that immune dysregulation plays a role in the pathogenesis of hypertension. Hypertensive patients exhibit increased levels of immunoglobulins and complement factors, along with decreased levels of certain lymphocyte subpopulations, indicating altered immune responses. This suggests potential for immunomodulatory strategies in managing hypertension.
Hypertensive disorders in pregnancy are common complications, affecting up to 10% of pregnancies. These disorders include chronic hypertension, gestational hypertension, and pre-eclampsia, with pre-eclampsia being particularly severe . The prevalence of HDP has been increasing, with significant disparities observed among different racial and socioeconomic groups. HDP is associated with severe maternal complications such as heart attack and stroke, and is a leading cause of pregnancy-related deaths in the United States.
Women who experience hypertensive disorders during pregnancy are at an increased risk of developing cardiovascular diseases later in life. This includes a higher likelihood of hypertension, stroke, and other cardiovascular conditions . Additionally, offspring of pregnancies affected by hypertensive disorders are at a higher risk of developing cardiovascular issues in adulthood, including elevated blood pressure and body mass index.
Recent advancements in the diagnosis and management of hypertensive disorders in pregnancy include early screening for pre-eclampsia and the use of targeted aspirin prophylaxis to reduce the number of affected pregnancies. Improved diagnostic methods, such as placental growth factor-based testing, have enhanced the identification of high-risk pregnancies. Despite these advancements, there remains a need for better adherence to postnatal guidelines to monitor and manage hypertension, and more research focused on preventing future cardiovascular diseases in women with a history of HDP.
The genetic architecture of hypertension is complex, with familial relationships accounting for about 50% of the variation in blood pressure among individuals. Omic approaches, including genomics, epigenomics, transcriptomics, proteomics, and metabolomics, have been employed to better understand the pathophysiology of hypertension. These methods have the potential to identify novel mechanisms and pathways involved in hypertension, paving the way for new diagnostic and therapeutic strategies.
Hypertension and hypertensive disorders of pregnancy are significant public health concerns with far-reaching implications for maternal and fetal health. Understanding the multifactorial nature of these conditions, including genetic, immunological, and environmental factors, is crucial for developing effective management and prevention strategies. Continued research and advancements in diagnostic and therapeutic approaches are essential to mitigate the long-term health risks associated with these disorders.
Most relevant research papers on this topic